Clinical Trials on Papillomavírus fertőzések

Total 817 results

The Alfred
Merck Sharp & Dohme LLC

Completed

Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2) (HYPER2)

Human Papillomavirus Infection | Human Papillomavirus

Australia
University of Cincinnati

Recruiting

Let's K-Talk - HPV Study for Ethnic Koreans

Papillomavirus Vaccines | Human Papillomavirus Viruses

United States
Kanazawa Medical University
Merck Sharp & Dohme LLC

Unknown

Changes in the Prevalence of Oncogenic HPV Types

Papillomavirus Infections | Papillomavirus Vaccines
GlaxoSmithKline

Completed

Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine

Infections, Papillomavirus | Papillomavirus Vaccines

Belgium, United States
GlaxoSmithKline

Completed

Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.

Infections, Papillomavirus | Papillomavirus Vaccines

Denmark, Poland, Lithuania
University of North Carolina, Chapel Hill
Centers for Disease Control and Prevention; American Cancer Society, Inc.; New... and other collaborators

Withdrawn

Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination in Integrated Healthcare Delivery Systems

Human Papillomavirus Infection

United States
Merck Sharp & Dohme LLC

Completed

A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)

Human Papillomavirus Infection
Sanford Health

Completed

Prevalence of Human Papillomavirus in Men Living in the Northern Plains

Human Papillomavirus Infection

United States
GlaxoSmithKline

Completed

An Observational Study on the Prevalence of Human Papillomavirus Types in Women in the Kingdom of Bahrain

Human Papillomavirus Infection

Bahrain
CHU de Quebec-Universite Laval
Centre hospitalier de l'Université de Montréal (CHUM); Institut National en... and other collaborators

Completed

ICI-VPH: Impact of HPV Immunisation Schedules Against HPV (ICI-VPH)

Human Papillomavirus Infections

Canada
Centre Hospitalier Universitaire de Besancon

Completed

Impact of HPV Vaccination on Cervical High Grade Lesions in France (IMPACT)

Human Papillomavirus Infection

France
University Hospital, Geneva

Completed

A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection

Human Papillomavirus Infection

Switzerland
University of Connecticut

Completed

An Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Among Women

Human Papillomavirus Infection
Indiana University
Merck Sharp & Dohme LLC

Unknown

Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers

Human Papillomavirus Infection

United States
Gen-Probe, Incorporated

Completed

Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System

Human Papillomavirus Infection

United States
GlaxoSmithKline

Completed

Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) Vaccine

Human Papillomavirus Infection
GlaxoSmithKline

Completed

An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in Egypt

Human Papillomavirus Infection

Egypt
University Hospital, Geneva

Unknown

Randomized Comparison of Vaginal Self Sampling for Human Papillomavirus (HPV) Testing by Standard Versus Dry Vaginal Swabs (HPVDry)

Human Papillomavirus Infection
Gen-Probe, Incorporated

Completed

APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results (AHPV-GT)

Human Papillomavirus Infection

United States
H. Lee Moffitt Cancer Center and Research Institute

Completed

The Human Papillomavirus (HPV) Transmission Pilot Study

Human Papillomavirus Infection

United States
Beijing Health Guard Biotechnology, Inc

Active, not recruiting

A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccine

Human Papillomavirus Infection

China
Wuhan BravoVax Co., Ltd.
Novotech (Australia) Pty Limited; Shanghai BravoBio Co., Ltd.

Not yet recruiting

Phase I Clinical Trial of a Candidate HPV Vaccine

Human Papillomavirus Infection

Australia
University of North Carolina, Chapel Hill
Centers for Disease Control and Prevention; New York State Department of Health and other collaborators

Completed

Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination

Human Papillomavirus Infection

United States
Merck Sharp & Dohme LLC

Completed

A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)

Human Papillomavirus Infection
Merck Sharp & Dohme LLC
Kaiser Permanente

Completed

Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASIL™ (V501-031)

Human Papillomavirus Infection
Danish Cancer Society
Merck Sharp & Dohme LLC

Completed

Prevalence and Type Distribution of Human Papillomavirus (HPV) in Tanzanian Men

Human Papillomavirus Infection

Denmark
GlaxoSmithKline

Withdrawn

Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka

Human Papillomavirus Infection
National Institute for Public Health and the Environment...

Terminated

Efficacy and Immunomodulation Study of Simultaneous Human Papillomavirus/ Hepatitis B (HPV/HBV) Vaccination (TANGO)

Human Papillomavirus Infection
Kaiser Permanente
National Cancer Institute (NCI)

Recruiting

Provider Recommendation and HPV Vaccination (HPVV)

Human Papillomavirus

United States
University of Alabama at Birmingham
National Cancer Institute (NCI)

Recruiting

Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors

Papillomavirus Vaccines

United States
Queen Mary University of London

Completed

Predictors of CIN Study Series 5.0:Stability Study in Vaginal Self-samples (Predictors50)

Human Papillomavirus
Lake Cumberland District Health Department
Merck Sharp & Dohme LLC

Completed

A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates

Human Papillomavirus

United States
The University of Hong Kong
Queen Mary Hospital, Hong Kong

Unknown

Psychosocial Effect of HPV Positivity

Human Papillomavirus

China
Global Alliance to Immunize Against AIDS Vaccine...
Merck Sharp & Dohme LLC

Unknown

KAP/WTP and HPV Prevalence Studies in a Developing World Setting (Bamako, Mali) (HPV)

Human Papillomavirus

Mali
Huong McLean, PhD
Centers for Disease Control and Prevention

Active, not recruiting

Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination

Papillomavirus Vaccines

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

Study of Gardasil in Mid-Adult Males (MAM)

Human Papillomavirus

United States, Mexico
Laval University

Completed

Immunogenicity of Gardasil and Twinrix and the Effect of a Dose of Gardasil or Cervarix Given 42 Months Later.

Human Papillomavirus

Canada
University Hospital, Toulouse

Completed

Detection of Human Papillomavirus in Polymerase Chain for Suspicious Lesions of the Amygdala: Concordance Smear-Biopsy (HPV-BIOFRO)

Human Papillomavirus

France
University of North Carolina, Chapel Hill
Harvard Medical School (HMS and HSDM); Pfizer; North Carolina Department of Health...

Completed

Making Effective Human Papillomavirus (HPV) Vaccine Recommendations

Human Papillomavirus

United States
Bezmialem Vakif University

Completed

Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal Cytology

Human Papillomavirus Infection
University of British Columbia
Merck Canada Inc.

Completed

Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine (Merck08)

Human Papillomavirus

Canada
University of North Carolina, Chapel Hill
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Normalizing HPV Vaccination in Preteens With a Serious Video Game

Human Papillomavirus

United States
Northwestern University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

txt2protect: Using Text Messaging to Increase HPV Vaccination Among Young Sexual Minority Men (t2p)

Human Papillomavirus

United States
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Tolerability of V503 Versus GARDASIL (V503-009)

Human Papillomavirus
Genexine, Inc.

Completed

Safety and Tolerability of GX-I7 in HPV-infected Female Volunteers

Human Papillomavirus

Korea, Republic of
Columbia University
Agency for Healthcare Research and Quality (AHRQ)

Completed

Interactive, Health Literacy Promoting Text Messages and HPV Vaccine Completion In Minority Adolescents

Human Papillomavirus

United States
Emory University

Completed

Tailoring of Vaccine-Focused Messages: Disease Salience

Human Papillomavirus

United States
University of Arkansas
National Cancer Institute (NCI)

Completed

A Phase I Clinical Trial of an HPV Therapeutic Vaccine

Human Papillomavirus

United States
Thai Red Cross AIDS Research Centre
amfAR, The Foundation for AIDS Research; South East Asia Research Collaboration... and other collaborators

Active, not recruiting

Anal HPV Infection and Risk for Anal High-grade Squamous Intraepithelial Lesion Among Thai MSM With Acute HIV Infection

Human Papillomavirus Infection

Thailand
Gen-Probe, Incorporated

Completed

Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System

Human Papillomavirus Infection

United States

Clinical Trials on Papillomavírus fertőzések

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations